- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of glycogen storage disease type I on adult daily life: a survey ; volume:16 ; number:1 ; day:3 ; month:9 ; year:2021 ; pages:1-10 ; date:12.2021
Orphanet journal of rare diseases ; 16, Heft 1 (3.9.2021), 1-10, 12.2021
- Creator
-
Garbade, Sven
Ederer, Viviane
Burgard, Peter
Wendel, Udo
Spiekerkötter, Ute
Haas, Dorothea
Grünert, Sarah
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-021-02006-w
- URN
-
urn:nbn:de:101:1-2021111620334437508593
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Garbade, Sven
- Ederer, Viviane
- Burgard, Peter
- Wendel, Udo
- Spiekerkötter, Ute
- Haas, Dorothea
- Grünert, Sarah
- SpringerLink (Online service)
Other Objects (12)
The phenotypic and genetic spectrum of glycogen storage disease type VI
Successful pregnancy in a woman with glycogen storage disease type 6
Three successful pregnancies in a patient with glycogen storage disease type 0
Impact of glycogen storage disease type I on adult daily life: a survey
Reversible sensory neuropathy in mitochondrial trifunctional protein deficiency
Severe loss of appetite and refusal to eat as severe side effect of glycerol phenylbutyrate
Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib
Newborn screening and disease variants predictneurological outcome in isovaleric aciduria
Metabolic profiling in human fibroblasts enables subtype clustering in glycogen storage disease
Entzugsphänomene beim Absetzen von Phenobarbital und Primidon : wovon sind sie abhängig?
Organoazidopathien im Blickpunkt des Neugeborenen-Screenings - Wandel des klinischen Phänotyps und kritische Aspekte des Screenings
Isovalerianazidämie : Klinik, Pathobiochemie und Therapie am Beispiel von 28 Patienten
The phenotypic and genetic spectrum of glycogen storage disease type VI
Successful pregnancy in a woman with glycogen storage disease type 6
Three successful pregnancies in a patient with glycogen storage disease type 0
Impact of glycogen storage disease type I on adult daily life: a survey
Reversible sensory neuropathy in mitochondrial trifunctional protein deficiency
Severe loss of appetite and refusal to eat as severe side effect of glycerol phenylbutyrate
Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib
Newborn screening and disease variants predictneurological outcome in isovaleric aciduria
Metabolic profiling in human fibroblasts enables subtype clustering in glycogen storage disease
Entzugsphänomene beim Absetzen von Phenobarbital und Primidon : wovon sind sie abhängig?
Organoazidopathien im Blickpunkt des Neugeborenen-Screenings - Wandel des klinischen Phänotyps und kritische Aspekte des Screenings
Isovalerianazidämie : Klinik, Pathobiochemie und Therapie am Beispiel von 28 Patienten
The phenotypic and genetic spectrum of glycogen storage disease type VI
Successful pregnancy in a woman with glycogen storage disease type 6
Three successful pregnancies in a patient with glycogen storage disease type 0
Impact of glycogen storage disease type I on adult daily life: a survey
Reversible sensory neuropathy in mitochondrial trifunctional protein deficiency
Severe loss of appetite and refusal to eat as severe side effect of glycerol phenylbutyrate
Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib
Newborn screening and disease variants predictneurological outcome in isovaleric aciduria
Metabolic profiling in human fibroblasts enables subtype clustering in glycogen storage disease
Entzugsphänomene beim Absetzen von Phenobarbital und Primidon : wovon sind sie abhängig?
Organoazidopathien im Blickpunkt des Neugeborenen-Screenings - Wandel des klinischen Phänotyps und kritische Aspekte des Screenings